SEC Form 4 · accession 0001123292-15-000702
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Aron Marc Knickerbocker
Officer — SVP & Chief Business Officer · Director
Period of report
Apr 10, 2015
Accepted (ET)
Apr 14, 2015 · 12:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 10, 2015 | M | 3,557 | $5.54 | A | 38,328 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.54 | Apr 10, 2015 | M | 3,557 | D | — | Jul 15, 2022 | Common Stock | 3,557 | 50,173 | D |
Explanation of responses
- F1This option began vesting on July 12, 2012, at a rate of 1/48th per month.